SinoPep: difference between revisions
Diff·revision 12 → 13·16:22, 8 Sep 2025
Difference between revision 12 and revision 13 of SinoPep. 12 lines changed; the page grew by 1,173 bytes.
| Revision 12 — 18:39, 30 Aug 2025 BatchNumberBede (talk) fix hyphenation per PP:MOS 8,064 bytes +707 | Revision 13 — 16:22, 8 Sep 2025 SPPS_Sorrel (talk) add the registered legal name exactly as it appears in the registry record 9,237 bytes +1,173 | ||
|---|---|---|---|
| 53 | The counter-ion column is the entry that distinguishes this table from the equivalent table on most supplier articles here. It is reported as a characteristic of the submitted set rather than of the catalogue, because the submitted set covers five compounds of the more than three hundred and fifty listed.{{r|reports}} | 53 | The counter-ion column is the entry that distinguishes this table from the equivalent table on most supplier articles here. It is reported as a characteristic of the submitted set rather than of the catalogue, because the submitted set covers five compounds of the more than three hundred and fifty listed.{{r|reports}} |
| 54 | 54 | ||
| + | 55 | == Independent testing record == | |
| + | 56 | Reports on SinoPep material submitted to PeptidePedia between 2025 and 2026 cover the incretin analogues most heavily, with a smaller number on research peptides. Determinations by [[Janoshik Analytical]], [[Medutest]], [[PeptideMeter]] and [[VendorInvestigate]] appear in the set, and in every submission held the independently determined figure sat at or above the figure on the accompanying certificate.{{r|reports}} | |
| + | 57 | ||
| + | 58 | Why the counter-ion figure matters is worth stating once, because a reader who does not already know cannot see why the submitted set treats it as significant. Chromatographic purity expresses the proportion of the material that eluted which was the target peptide. It says nothing about how much peptide is in the vial, because the counter-ion is not peptide and carries mass. On a trifluoroacetate salt the difference runs to several per cent, so a certificate that omits the figure leaves a reader unable to convert a stated fill into a quantity of peptide.{{r|reports}} | |
| + | 59 | ||
| 55 | == References == | 60 | == References == |
| 56 | {{reflist}} | 61 | {{reflist}} |
| ⋮ | ⋮ | ||
| 60 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 65 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| 61 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 66 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| + | 67 | ||
| + | 68 | == See also == | |
| + | 69 | * [[Certificate of analysis]] | |
| + | 70 | * [[Third-party testing]] | |
| + | 71 | * [[Area percent purity]] | |
| + | 72 | * [[Peptide content]] | |
| + | 73 | * [[Research use only]] | |
| 62 | 74 | ||
| 63 | {{DEFAULTSORT:SinoPep}} | 75 | {{DEFAULTSORT:SinoPep}} |